31722-085 : Apremilast 30 mg Oral Tablet, Film Coated
| NDC: | 31722-085 |
| Labeler: | Camber Pharmaceuticals, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Apremilast |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | ANDA211878 |
| Rev. Date: |
NDC Package Codes:
- 31722-085-60: 60 TABLET, FILM COATED IN 1 BOTTLE (31722‑085‑60)
Active Ingredients:
- Apremilast
Dosage Strength:
- 30 mg
Pharmaceutical Classes:
- Phosphodiesterase 4 Inhibitor [EPC]
- Phosphodiesterase 4 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 31722-086 ApremilastApremilast Kit by Camber Pharmaceuticals, Inc.
- 31722-087 ApremilastApremilast Kit by Camber Pharmaceuticals, Inc.
- 60219-1410 Apremilast 30 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
- 60219-1744 ApremilastApremilast Oral Kit by Amneal Pharmaceuticals Ny LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 31722-078Next: 31722-086 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.